UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Journal of clinical oncology, ISSN 0732-183X, 04/2012, Volume 30, Issue 10, pp. 1080 - 1086
Life Sciences & Biomedicine | Oncology | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | Biological and medical sciences | Medical sciences | Tumors | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Survivors - statistics & numerical data | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Breast Neoplasms - physiopathology | Cyclophosphamide - adverse effects | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Time Factors | Aged, 80 and over | Female | Survivors - psychology | Chemotherapy, Adjuvant | Psychomotor Performance - drug effects | Cognition - drug effects | Breast Neoplasms - drug therapy | Neuropsychological Tests | Methotrexate - adverse effects | Breast Neoplasms - psychology | Methotrexate - administration & dosage | Aged | Cohort Studies | Executive Function - drug effects | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 377, Issue 9762, pp. 321 - 331
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | Biological and medical sciences | General aspects | Medical sciences | Tumors | Receptors, Estrogen - metabolism | Adenocarcinoma - pathology | Humans | Middle Aged | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Breast Neoplasms - therapy | Disease-Free Survival | Adenocarcinoma - metabolism | Adenocarcinoma - therapy | Breast Neoplasms - pathology | Antineoplastic Agents, Hormonal - therapeutic use | Tamoxifen - therapeutic use | Aged, 80 and over | Postmenopause | Adult | Breast Neoplasms - mortality | Female | Aged | Androstadienes - therapeutic use | Early Diagnosis | Adenocarcinoma - mortality | Disease | Womens health | Meetings | Data collection | Breast cancer | Mammography | Family medical history | Clinical medicine | Cancer therapies | Index Medicus | Abridged Index Medicus | Ethics | Side effects | Hospitals | thromboembolism | survival | musculoskeletal system | post-menopause | Cancer
Journal Article
British journal of cancer, ISSN 0007-0920, 01/2018, Volume 119, Issue 4, pp. 408 - 418
Journal Article
Scientific reports, ISSN 2045-2322, 02/2021, Volume 11, Issue 1, pp. 3249 - 3249
Journal Article
Breast cancer research and treatment, ISSN 0167-6806, 04/2016, Volume 156, Issue 3, pp. 557 - 566
Chemotherapy | Dose intensity | Breast cancer | Toxicity | BRCA mutation | Medicine & Public Health | Oncology | Life Sciences & Biomedicine | Science & Technology | Anthracyclines - adverse effects | Chemotherapy-Induced Febrile Neutropenia - epidemiology | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Linear Models | Breast Neoplasms - drug therapy | Dose-Response Relationship, Drug | Young Adult | BRCA1 Protein - genetics | Taxoids - administration & dosage | Anthracyclines - administration & dosage | Breast Neoplasms - genetics | Chemotherapy, Adjuvant - adverse effects | Germ-Line Mutation | Adult | Female | Neoplasm Recurrence, Local - genetics | Aged | Retrospective Studies | BRCA2 Protein - genetics | Taxoids - adverse effects | Proteins | Women | Anthracyclines | Care and treatment | Analysis | Adjuvant treatment | Genetic aspects | Health aspects | Cancer | Index Medicus | Epidemiology
Journal Article
Neoplasia (New York, N.Y.), ISSN 1476-5586, 2016, Volume 18, Issue 11, pp. 647 - 653
Oncology | Life Sciences & Biomedicine | Science & Technology | Receptors, Estrogen - metabolism | Prognosis | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Neoplastic Cells, Circulating - metabolism | Treatment Outcome | Biomarkers, Tumor | Breast Neoplasms - drug therapy | Breast Neoplasms - metabolism | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Aged, 80 and over | Adult | Breast Neoplasms - mortality | Female | Aged | Index Medicus
Journal Article
Breast cancer research and treatment, ISSN 0167-6806, 11/2015, Volume 154, Issue 1, pp. 171 - 180
Risk-reducing mastectomy | Radiotherapy | Contralateral breast cancer | BRCA mutation | Breast-conserving surgery | Medicine & Public Health | Oncology | Life Sciences & Biomedicine | Science & Technology | Breast Neoplasms - surgery | Humans | Middle Aged | Risk Factors | Proportional Hazards Models | Neoplasms, Second Primary - radiotherapy | Neoplasms, Second Primary - surgery | BRCA1 Protein - genetics | Breast Neoplasms - radiotherapy | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Radiotherapy, Adjuvant - adverse effects | Mastectomy | Adult | Female | Aged | Mutation | Neoplasms, Second Primary - genetics | Neoplasms, Second Primary - pathology | BRCA2 Protein - genetics | Lumpectomy | Care and treatment | Cancer patients | Ionizing radiation | Gene mutations | Breast cancer | Genetic aspects | Health aspects | Risk factors | Cancer | Index Medicus | Epidemiology
Journal Article
Human brain mapping, ISSN 1065-9471, 2014, Volume 35, Issue 3, pp. 889 - 899
magnetic resonance imaging | axons | adjuvant | breast neoplasms | diffusion tensor imaging | time | brain | chemotherapy | Axons | Brain | Chemotherapy | Magnetic resonance imaging | Adjuvant | Breast neoplasms | Time | Diffusion tensor imaging | Neuroimaging | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Radiodiagnosis. Nmr imagery. Nmr spectrometry | Biological and medical sciences | Nervous system | Investigative techniques, diagnostic techniques (general aspects) | Medical sciences | Leukoencephalopathies - pathology | Cyclophosphamide - administration & dosage | Cross-Sectional Studies | Humans | Middle Aged | Survivors | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Breast Neoplasms - drug therapy | Cyclophosphamide - adverse effects | Brain - drug effects | Diffusion Tensor Imaging - methods | Methotrexate - adverse effects | Fluorouracil - administration & dosage | Leukoencephalopathies - chemically induced | Fluorouracil - adverse effects | Time Factors | Antineoplastic Agents - adverse effects | Chemotherapy, Adjuvant - adverse effects | Brain - pathology | Diffusion Tensor Imaging - instrumentation | Female | Methotrexate - administration & dosage | Aged | Cancer survivors | Cyclophosphamide | Anisotropy | Adjuvant treatment | Breast cancer | Methotrexate | Cancer | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 03/2010, Volume 28, Issue 8, pp. 1294 - 1300
Gynecology. Andrology. Obstetrics | Mammary gland diseases | Biological and medical sciences | Medical sciences | Tumors | Aromatase Inhibitors - administration & dosage | Prospective Studies | Antineoplastic Agents, Hormonal - administration & dosage | Cognition Disorders - chemically induced | Humans | Middle Aged | Selective Estrogen Receptor Modulators - adverse effects | Selective Estrogen Receptor Modulators - administration & dosage | Breast Neoplasms - drug therapy | Tamoxifen - administration & dosage | Case-Control Studies | Randomized Controlled Trials as Topic | Antineoplastic Agents, Hormonal - adverse effects | Aromatase Inhibitors - adverse effects | Netherlands | Androstadienes - administration & dosage | Aged, 80 and over | Postmenopause | Female | Aged | Tamoxifen - adverse effects | Androstadienes - adverse effects | Index Medicus
Journal Article
Breast cancer research and treatment, ISSN 0167-6806, 4/2018, Volume 168, Issue 2, pp. 413 - 420
Postmenopausal | IDEAL | Medicine & Public Health | Extended | Oncology | Subgroup | Adjuvant | Letrozole | Life Sciences & Biomedicine | Science & Technology | Receptors, Estrogen - metabolism | Follow-Up Studies | Humans | Middle Aged | Netherlands - epidemiology | Kaplan-Meier Estimate | Breast Neoplasms - drug therapy | Disease-Free Survival | Time Factors | Breast Neoplasms - pathology | Chemotherapy, Adjuvant - methods | Antineoplastic Agents, Hormonal - therapeutic use | Lymphatic Metastasis - pathology | Postmenopause | Breast Neoplasms - mortality | Female | Aged | Aromatase Inhibitors - therapeutic use | Medical research | Care and treatment | Analysis | Medicine, Experimental | Postmenopausal women | Breast cancer | Tamoxifen | Health aspects | Cancer | Index Medicus | Clinical Trial
Journal Article
The New England journal of medicine, ISSN 0028-4793, 08/2009, Volume 361, Issue 7, pp. 653 - 663
Gynecology. Andrology. Obstetrics | Mammary gland diseases | Biological and medical sciences | General aspects | Medical sciences | Tumors | Lymph Node Excision | Breast Neoplasms - surgery | Lymph Nodes - pathology | Follow-Up Studies | Humans | Middle Aged | Treatment Outcome | Breast Neoplasms - drug therapy | Case-Control Studies | Disease-Free Survival | Breast Neoplasms - pathology | Lymphatic Metastasis - pathology | Age of Onset | Aged, 80 and over | Axilla | Adult | Female | Aged | Sentinel Lymph Node Biopsy | Chemotherapy, Adjuvant | Neoplasm Staging | Breast cancer | Diagnosis | Metastasis | Research | Patient outcomes | Lymphatic system | Biopsy | Dissection | Cancer therapies | Index Medicus | Abridged Index Medicus
Journal Article